Clinical Trial Update: Vitamin D Pilot Study in Patients With Multiple Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 pilot trial evaluating Vitamin D (cholecalciferol) in Relapsing Remitting Multiple Sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 1 | Status: COMPLETED